Literature DB >> 1127872

Acute cholestasis induced by lithocholic acid in the rat. A freeze-fracture replica and thin section study.

K Miyal, W W Mayr, A L Richardson.   

Abstract

Sodium lithocholate (LCA) was continuously infused intravenously (0.1 or 0.2 mumole per minute per 100 gm. body weight) in Wistar rats with a bile fistula for up to 4 hours. The higher dose induced complete cholestasis within 2 to 3 hours, whereas the low dose reduced the biliary output to less than 10 per cent of the preinfusion level by the 3rd hour. Ultrastructural changes which were primarily localized to the bile canaliculi and the pericanalicular region were seen 30 minutes after the onset of bile acid infusion. Dilation of the bile carnaliculi, loss of canalicular microvilli, prominence of the pericanalicular ectoplasm, and a characteristic lamellar transformation of the canalicular membrane developed, which became more prominent and widespread with progression of time. A freeze-fracture replica study revealed that the canalicular microvilli became transformed through widening and flattening into multilamellar foldings. Intramembranous granules of the canalicular membrane appeared to have become redistributed, being few or absent in the "transformed" regions. In addition, a sharply angulated, crystalline material was seen in occasional bile canaliculi. This material appeared as a negative image in thin sections, indicating its solubility in organic solvents which were used for dehydration. With the lower dose of LCA, subcellular changes were similar to, but less severe and which accompany an acute cholestasis induced by LCA is attributable to the accumulation of this compound in the bile canaliculus and its vicinity. LCA presumably causes an asymmetric perturbation in the molecular organization of the canalicular membrane which results in ultrastructural alterations and failure of fluid transport. In addition, precipitates of LCA appear to form in the bile canaliculi and may contribute to cholestasis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127872

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  15 in total

1.  Taurolithocholate impairs bile canalicular motility and canalicular bile secretion in isolated rat hepatocyte couplets.

Authors:  Norihito Watanabe; Tatehiro Kagawa; Seiichiro Kojima; Shinji Takashimizu; Naruhiko Nagata; Yasuhiro Nishizaki; Tetsuya Mine
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

2.  Intrahepatic cholestasis as a side-effect of drug therapy.

Authors:  G Feuer; M S Dhami
Journal:  Can Fam Physician       Date:  1982-07       Impact factor: 3.275

3.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity.

Authors:  J L Staudinger; B Goodwin; S A Jones; D Hawkins-Brown; K I MacKenzie; A LaTour; Y Liu; C D Klaassen; K K Brown; J Reinhard; T M Willson; B H Koller; S A Kliewer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Taurolithocholate inhibits taurocholate uptake by isolated hepatocytes at low concentrations.

Authors:  M Schwenk; L R Schwarz; H Greim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

5.  A STAT factor mediates the sexually dimorphic regulation of hepatic cytochrome P450 3A10/lithocholic acid 6 beta-hydroxylase gene expression by growth hormone.

Authors:  A Subramanian; J Teixeira; J Wang; G Gil
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

6.  Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation.

Authors:  Kathleen G Barrett; Hailin Fang; Daniela Cukovic; Alan A Dombkowski; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Drug Metab Dispos       Date:  2015-05-06       Impact factor: 3.922

7.  The lithocholic acid 6 beta-hydroxylase cytochrome P-450, CYP 3A10, is an active catalyst of steroid-hormone 6 beta-hydroxylation.

Authors:  T K Chang; J Teixeira; G Gil; D J Waxman
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

8.  [Different effect of taurolithocholate and chenodeoxycholate on structure and function of isolated hepatocytes (author's transl)].

Authors:  J Schölmerich; K Schmidt; B Kremer; M S Becher; W Gerok
Journal:  Klin Wochenschr       Date:  1981-06-15

9.  Lithocholate-3-O-glucuronide-induced cholestasis. A study with congenital hyperbilirubinemic rats and effects of ursodeoxycholate conjugates.

Authors:  H Takikawa; K Minagawa; N Sano; M Yamanaka
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

10.  Hepatic metabolism of 3 alpha-hydroxy-5 beta-etianic acid (3 alpha-hydroxy-5 beta-androstan-17 beta-carboxylic acid) in the adult rat.

Authors:  J M Little; J St Pyrek; R Lester
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.